GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.10.23	GSK: Phase III Trial Of Jemperli + Chemotherapy Meets OS Endpoint In Recurrent Endometrial Cancer (RTTNews)
25.10.23	GSK: New Data Shows RSV Vaccine's Potential In Adults Aged 50 To 59 At Increased Risk For RSV-LRTD (RTTNews)
16.10.23	GSK: EU's CHMP Recommends Approval Of Jemperli Plus Chemotherapy In Certain Endometrial Cancer (RTTNews)
11.10.23	GSK Confirms Settlement In Cantlay/Harper Case (RTTNews)
09.10.23	IDEAYA Biosciences Selects Werner Helicase Inhibitor Development Candidate With GSK (RTTNews)
26.09.23	Scynexis Recalls GSK- Licensed Ibrexafungerp Tablets, Halts Trials On Contamination Concerns (RTTNews)
25.09.23	GSK Plc Announces Approval Of Arexvy In Japan - Quick Facts (RTTNews)
19.09.23	GSK : EC Authorizes ViiV Healthcare's Apretude For HIV Prevention (RTTNews)
18.09.23	GSK Plc: FDA Approves Ojjaara For Myelofibrosis Patients With Anaemia - Quick Facts (RTTNews)
01.09.23	GSK Plc: MHLW In Japan To Review Supplementary New Drug Application For Nucala (RTTNews)
31.08.23	Biotech Stocks Facing FDA Decision In September 2023 (RTTNews)
23.08.23	GSK Plc Reports 100% Vaccine Efficacy From Post-license Phase IV Trial Of Shingrix In China (RTTNews)
21.08.23	IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101 (RTTNews)
01.08.23	GSK : FDA Approves New Use For Jemperli Plus Chemotherapy (RTTNews)
24.07.23	GSK : ViiV's Cabotegravir For HIV Prevention Receives Positive CHMP Opinion From EMA (RTTNews)
13.07.23	GSK Begins Shipping Doses Of Quadrivalent Influenza Vaccines To US For 2023-24 Flu Season (RTTNews)
27.06.23	FDA Grants Fast Track Designation For GSK's Neisseria Gonorrhoeae Investigational Vaccine (RTTNews)
26.06.23	GSK :daprodustat Gets Positive CHMP Opinion For Treatment Of Symptomatic Anaemia Associated With CKD (RTTNews)
23.06.23	GSK Reaches Confidential Settlement Over Zantac Litigation (RTTNews)
22.06.23	GSK : CDC's Panel Votes To Recommend Arexvy For Prevention Of RSV Disease In Older Adults (RTTNews)
21.06.23	GSK Plc: New Data Shows Vaccine Efficacy Of Arexvy Against RSV-lower Respiratory Tract Disease (RTTNews)
07.06.23	GSK's Arexvy, RSV Vaccine For Older Adults, Authorized By European Commission (RTTNews)
12.05.23	GSK To Sell Up To 2.5% Of Haleon's Shares (RTTNews)
04.05.23	FDA Approves GSK's Arexvy, World's First RSV Vaccine For Older Adults (RTTNews)
27.04.23	GSK's Respiratory Syncytial Virus Older Adult Vaccine Candidate Gets Positive CHMP Opinion (RTTNews)
26.04.23	GSK Q1 Adj. Operating Profit Stable At CER, Affirms 2023 Guidance (RTTNews)
18.04.23	GSK To Buy BELLUS Health In US$2.0 Bln Deal (RTTNews)
17.04.23	GSK Plc: Gepotidacin Shows Non-inferiority To Nitrofurantoin In EAGLE-2 And EAGLE-3 Phase III Trials (RTTNews)
30.03.23	GSK, SCYNEXIS Ink Exclusive Licence Agreement For Brexafemme (RTTNews)
28.03.23	GSK Announces Positive Results From Phase III Trial Of Jemperli Combination In Endometrial Cancer (RTTNews)
28.03.23	Phase III RUBY clinical trial demonstrates potential of Jemperli (dostarlimab-gxly) plus chemotherapy to redefine the treatment of primary advanced or recurrent endometrial cancer versus chemother... (PR Newswire)
24.03.23	GSK Disagrees With Ruling By California State Court - Quick Facts (RTTNews)
14.03.23	GSK Announces Positive Phase III Data For 5-in-1 Meningococcal ABCWY Vaccine Candidate (RTTNews)
14.03.23	GSK : China Accepts Regulatory Submission For Nucala In Severe Eosinophilic Asthma (RTTNews)
02.03.23	FDA Panel Backs GSK's RSV Vaccine For Older Adults (RTTNews)
10.02.23	GSK Plc: FDA Grants Approval For Jemperli For Patients With DMMR Recurrent Endometrial Cancer (RTTNews)
10.02.23	US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer (PR Newswire)
02.02.23	FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis (RTTNews)
01.02.23	GSK Q4 Profit Climbs, Sees Growth In FY23; Says Confident Of FY26 View (RTTNews)
01.02.23	GSK: FDA Grants Orphan Drug Designation To Benlysta For Treatment Of Rare Autoimmune Disease (RTTNews)
29.01.23	Biotech Stocks Facing FDA Decision In February 2023 (RTTNews)
05.01.23	WuXi Enters Into License Deal With GSK On Multiple Novel Bi- & Multi-specific T Cell Engagers (RTTNews)
05.01.23	WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers (PR Newswire)
07.12.22	GSK Welcomes MDL Court Ruling - Quick Facts (RTTNews)
02.12.22	GSK Plc: Jemperli RUBY Phase III Trial Meets Primary Endpoint - Quick Facts (RTTNews)
22.11.22	GSK Initiates Process For Withdrawal Of US Marketing Authorization For Blood Cancer Drug Blenrep (RTTNews)
11.11.22	GSK To Restrict Second-line Maintenance Indication For Zejula In U.S. (RTTNews)
11.11.22	European Commission Approves Sanofi-GSK COVID Booster Vaccine (RTTNews)
07.11.22	GSK Plc: DREAMM-3 Phase III Trial For Blenrep Fails To Meet Primary Endpoint (RTTNews)
02.11.22	GSK Q3 Profit From Cont. Opns Down; Lifts 2022 Sales Growth Outlook (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft